Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm1.5k ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Toyota announces 2027 bZ prices start at $35,000 130

Students To Help Identify Retirement Options for Energy Technologies 124

Lucid’s smaller Cosmos SUV, slated for 2026, has been pushed back to 2027 119

6.5 Million Americans Face Landslide Risks — A New Database Shows Where They Live 118

Social influence can help tackle climate change 116

After the Palisades and Eaton fires, research offers new answers for communities as they rebuild 115

EVgo is putting 500+ fast chargers where Americans shop 114

Satellite Imagery Could Protect Trees From Devastating Moth Outbreaks 113

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.